Sentiment-Signal
10,6
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (04.02.2026)
HOCH Abgang Schlüsselpersonen (04.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 04.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | es laws of any such state or jurisdiction. Item 5.02 Departure of Directors or Certain Officers; Election of Directors |
| 05.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to be effective as of September 11, 2025. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; |
| 12.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 06.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ge Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce |
| 23.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | isdiction. 2 Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain O |
| 03.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ge Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Of |
| 14.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | change Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certa |
| 07.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Resignation of Director On July 5, 2023, Donald J. Tringali resigned from the board of the Company. |
Stammdaten
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Unternehmen & Branche
| Name | FIREFLY NEUROSCIENCE, INC. |
|---|---|
| Ticker | AIFF |
| CIK | 0000803578 |
| Boerse | US |
| Sektor | Technology |
| Industrie | Software - Application |
| SIC | 7372 · Services-Prepackaged Software |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 29,6 Mio. USD |
| Beta | 0,58 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,142,000 | -19,882,000 | 10,477,000 | 7,637,000 | |
| 2025-09-30 | 10-Q | 388,000 | -2,639,000 | -0.20 | 12,407,000 | 9,657,000 |
| 2025-06-30 | 10-Q | 299,000 | -1,833,000 | 14,938,000 | 12,100,000 | |
| 2025-03-31 | 10-Q | 43,000 | -12,930,000 | 12,363,000 | 5,185,000 | |
| 2024-12-31 | 10-K | 108,000 | -10,460,000 | 4,601,000 | -375,000 | |
| 2024-09-30 | 10-Q | 33,000 | -4,289,000 | -0.61 | 5,311,000 | -2,775,000 |
| 2024-06-30 | 10-Q | 10,000 | -1,264,000 | -0.58 | 3,309,914 | -1,215,000 |
| 2024-03-31 | 10-Q | 12,000 | -1,122,000 | 3,764,723 | -9,000 | |
| 2023-12-31 | 10-K | 498,000 | -2,603,000 | 2,641,000 | 109,000 | |
| 2023-09-30 | 10-Q | 23,000 | -650,000 | 5,261,805 | -1,028,000 | |
| 2023-06-30 | 10-Q | 234,785 | 0.36 | 6,247,302 | -1,729,000 | |
| 2023-03-31 | 10-Q | -1,349,952 | 7,290,035 | 2,371,318 | ||
| 2022-12-31 | 10-K | 12,022,952 | -17,753,838 | 7,981,214 | -2,226,000 | |
| 2022-09-30 | 10-Q | 2,306,379 | -4,700,519 | -0.26 | 16,607,691 | 12,629,881 |
| 2022-06-30 | 10-Q | -1,525,442 | -0.09 | 20,164,338 | 14,714,355 | |
| 2022-03-31 | 10-Q | -2,078,307 | -0.12 | 21,222,990 | 15,701,840 | |
| 2021-12-31 | 10-K | 15,033,504 | -1,131,449 | -0.09 | 23,362,643 | 17,441,172 |
| 2021-09-30 | 10-Q | -95,527 | -0.01 | 9,419,819 | 5,641,983 | |
| 2021-06-30 | 10-Q | 43,157 | 0.00 | 6,853,212 | 2,845,027 | |
| 2021-03-31 | 10-Q | 270,815 | 0.02 | 4,738,137 | 2,411,458 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-10-22 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -78,031 | 2.07 | -161,734.85 | -159,2% | |
| 2025-10-21 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -19,222 | 2.40 | -46,140.49 | -45,4% | |
| 2025-10-20 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -33,500 | 2.46 | -82,309.50 | -81,0% | |
| 2025-10-17 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -45,036 | 2.55 | -114,670.66 | -112,9% | |
| 2025-10-16 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -40,139 | 2.65 | -106,456.66 | -104,8% | |
| 2025-10-15 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -17,500 | 2.74 | -48,027.00 | -47,3% | |
| 2025-10-14 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -29,500 | 2.74 | -80,800.50 | -79,5% | |
| 2025-10-13 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -32,136 | 2.65 | -85,240.74 | -83,9% | |
| 2025-10-10 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -74,810 | 2.70 | -201,942.11 | -198,8% | |
| 2025-10-09 | Windsor Private Capital LP | 10% Owner | Open Market Sale | -30,126 | 2.94 | -88,693.96 | -87,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.